Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future. (2017)
Attributed to:
Rare disease use of clinical trial simulation for the chioce and optimization of study designs/Priomedchild Call/ER
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpt.659
PubMed Identifier: 28182269
Publication URI: http://europepmc.org/abstract/MED/28182269
Type: Journal Article/Review
Volume: 101
Parent Publication: Clinical pharmacology and therapeutics
Issue: 5
ISSN: 0009-9236